An observational pharmacokinetic study of ceftolozane-tazobactam in intensive care unit patients with and without continuous renal replacement therapy (2016–2019)

Grant type:
Merck Sharp & Dohme Australia
Researchers:
Funded by:
Merck, Sharp & Dohme